Aortic valve stenosis

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 2 Phase II: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • Kardigan Inc. Commercial
    ATACIGUAT
    2025-522176-86-01 7 countries n=496
    Pending
  • Oslo University Hospital HF Academic
    IMP not specified
    2023-510211-20-00 1 country 2021 n=360
    Ended

Phase II

1 trial
  • Novartis Pharma AG Commercial
    PELACARSEN
    2022-502135-19-00 10 countries 2024 n=234
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II 1
Kardigan Inc. Commercial 1 Phase III 0
Oslo University Hospital HF Academic 1 Phase III 0
New trials by year
2021
1
2024
1
← All indication landscapes